WHO ICTRP trial
Is pramipexole effective as an add-on treatment for people with…
ISRCTN84666271 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting
Key facts
| Trial ID | ISRCTN84666271 |
|---|---|
| Public title | Is pramipexole effective as an add-on treatment for people with treatment-resistant depression? |
| Scientific title | Randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression |
| Primary sponsor | University of Oxford |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase IV |
| Countries | United Kingdom;England |
| Conditions | Treatment resistant depression Mental and Behavioural Disorders |
| Interventions | In addition to their standard antidepressant medication, participants will be randomised 1:1 to receive either Pramipexole dihydrochloride monohydrate or a matched placebo. Randomisation will be via minimisation facilitated by an online… |
| Registration date | May 15, 2019 |
| Target size | 178 |
| Secondary IDs | 2019-001023-13;Ox_Psych_PAXD, IRAS 253702 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: